Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
chen shuang ya[Author]
(2 results)?
Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer.
Sci Transl Med. 2021 Oct 6;13(614):eabg6428. doi: 10.1126/scitranslmed.abg6428. Epub 2021 Oct 6.
Sci Transl Med. 2021.
PMID: 34613810
NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells.
Ma CS, Lv QM, Zhang KR, Tang YB, Zhang YF, Shen Y, Lei HM, Zhu L.
Ma CS, et al.
Acta Pharmacol Sin. 2021 Apr;42(4):613-623. doi: 10.1038/s41401-020-0443-1. Epub 2020 Jul 23.
Acta Pharmacol Sin. 2021.
PMID: 32704041
Free PMC article.
Item in Clipboard
Author Correction: NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells.
Ma CS, Lv QM, Zhang KR, Tang YB, Zhang YF, Shen Y, Lei HM, Zhu L.
Ma CS, et al.
Acta Pharmacol Sin. 2023 Nov;44(11):2346. doi: 10.1038/s41401-023-01131-5.
Acta Pharmacol Sin. 2023.
PMID: 37528234
Free article.
No abstract available.
Item in Clipboard
Cite
Cite